Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy

ConclusionsCardiac leiomyosarcoma is a rare tumor with a dismal prognosis. Surgery is the mainstay of treatment. Adjuvant treatment is still controversial.
Source: Clinical Sarcoma Research - Category: Cancer & Oncology Source Type: research